hybridoma
antibodi
direct
polypeptid
murin
hepat
jhm
strain
test
abil
alter
cours
normal
lethal
intracerebr
viru
challeng
three
monoclon
antibodi
direct
two
distinct
epitop
glycoprotein
protect
mice
lethal
viru
challeng
convert
infect
fatal
encephalomyel
demyelin
singl
neutral
antihodi
direct
third
epitop
well
seven
nonneutr
antibodi
ez
el
n
polypeptid
protect
challeng
mice
receiv
protect
antibodi
infect
block
howev
viru
grew
lower
titer
liver
brain
viru
replic
cn
restrict
unprotect
mice
decreas
involv
neuron
brain
protect
mice
observ
evid
neuron
infect
spinal
cord
found
contrast
oligodendrocyt
infect
presenc
protect
antibodi
evid
demylin
associ
mononuclear
cell
infiltr
found
studi
demonstr
antibodi
singl
epitop
viral
glycoprotein
substanti
alter
cours
phenotyp
diseas
murin
hepat
strain
jhm
neurotrop
member
coronavirida
infect
mous
associ
enceph
demyelin
bailey
et
al
waksman
adam
weiner
fatal
enceph
associ
signific
loss
neuron
normal
outcom
intracerebr
inocul
resist
mice
fatal
diseas
appar
control
singl
autosom
recess
gene
knobler
et
al
express
level
neuron
macrophag
recoveri
acut
enceph
rare
infrequ
survivor
exhibit
demyelin
lampert
et
weiner
haspel
cowork
temperatur
sensit
mutant
design
ts
produc
demyelin
infect
mice
produc
enceph
less
ts
mutant
infect
oligodendrocyt
lead
cell
death
degener
remov
myelin
sheath
macrophag
knobler
et
mous
hepat
virus
contain
least
three
major
class
structur
protein
includ
nucleocapsid
protein
n
two
glycoprotein
el
wege
et
az
sturman
et
al
holm
et
al
el
integr
associ
membran
nonglycosyl
z
form
oglycosyl
form
consist
two
approxim
subunit
form
dimer
constitut
larg
petal
peplom
virion
envelop
sturman
et
al
laboratori
rais
librari
hybridoma
antibodi
viral
protein
studi
biolog
biochemistri
mhv
probe
vivo
event
viml
neutral
viru
neutral
diseas
antibodi
capac
ascit
fluid
contain
monoabl
initi
studi
assign
clonal
antibodi
quantit
viral
compon
respons
attachplaqu
reduct
neutral
assay
asment
cellcel
fusion
glycit
fluid
dilut
mem
indicoprotein
collin
et
ak
map
cate
mix
equal
volum
epitop
region
molecul
ml
viru
dilut
contain
talbot
et
al
report
pfu
virusantibodi
mixstudi
abil
antibodi
specif
ture
incub
min
viral
protein
alter
cours
diseas
divid
half
plate
duplic
vivo
map
properti
monolay
cell
cultur
passiv
protect
lethal
encephdish
adsorpt
hr
overlay
aliti
specif
epitop
glymedium
ad
plate
coprotein
incub
hr
coz
incub
cell
fix
addit
ml
formalin
pb
materi
method
hr
agar
overlay
remov
monolay
stain
crystal
viviru
cell
cultur
jhm
olet
neutral
express
strain
origin
obtain
dr
reciproc
antibodi
dilut
give
lesli
weiner
routin
propag
reduct
plaqu
number
compar
cell
previous
describ
haswith
viru
incub
parallel
culpel
et
al
collin
et
al
ts
ture
medium
contain
antibodi
mutant
produc
high
cite
fluid
direct
nonneutralfrequ
demyelin
diseas
withiz
antigen
nucleocapsid
enceph
isol
haspel
et
protein
unrel
virus
c
viru
enumer
plaqu
often
exhibit
low
level
assay
cell
neutral
activ
prd
ml
hybridwmu
cell
hybridoma
cell
prothu
control
sampl
consist
nuduc
monoclon
antibodi
cleocapsid
antibodi
includ
aswer
gener
character
say
laboratori
previous
describ
collin
passiv
antibodi
protect
assesset
line
clone
limment
demyelin
balbc
st
mice
ite
dilut
plate
ratio
age
week
exquisit
sensit
cell
per
well
specif
viral
intracerebr
ic
infect
polypeptid
epitop
establish
knobler
et
al
develop
rapa
describ
elsewher
collin
et
al
idli
fatal
enceph
due
infect
talbot
et
al
neuron
use
ic
infect
ascit
fluid
produc
balb
mice
test
system
assess
proc
st
mice
briefli
mice
pretreat
tectiv
effect
passiv
administ
ip
inject
ml
pristan
monoclon
antibodi
infect
aldrich
two
protocol
antibodi
administr
chemic
co
milwauke
wise
seven
day
later
x
x
hybridoma
employ
initi
experi
gave
mice
daili
dose
undilut
cell
inject
intraperiton
asascit
day
rel
cite
develop
day
later
viru
challeng
day
order
harvest
daili
unanesthet
mice
minim
handl
mice
infect
punctur
needl
ascit
subsequ
adopt
protocol
fluid
clarifi
centrifug
g
min
aliquot
store
singl
dose
ascit
day
found
regimen
effici
immunoglobulin
concentr
first
confer
protect
ascit
fluid
estim
radial
imcas
viru
challeng
consist
munodiffus
pfu
approxim
ld
wildtyp
intracerebr
dose
reproduc
yield
mortal
day
infect
assess
demyelin
passiv
protect
mice
allow
survivor
live
day
viru
challeng
sacrif
perfus
via
left
ventricl
glutaraldehydeparaformaldehyd
fix
pb
previous
describ
knobler
et
al
follow
perfus
spinal
cord
brain
dissect
lpm
epon
section
prepar
stain
myelin
withp
phenylenediamin
survey
demyelin
foci
routin
includ
examin
two
section
cervic
lumbar
spinal
cord
one
section
thorac
cord
anim
judg
demyelin
foci
axon
demyelin
observ
white
matter
five
section
immunoperoxidas
stain
viral
antigen
perform
vibratom
section
previous
describ
knobler
et
al
use
protein
peroxidas
monospecif
rabbit
antibodi
kindli
suppli
k
v
holm
usph
bethesda
md
antigen
studi
glutaraldehyd
omit
perfus
fix
viru
titrat
homogen
specifi
tissu
prepar
mice
infect
treat
indic
assay
monolay
cell
viru
titer
express
pfu
per
gram
tissu
bg
mcmoclon
antibodi
previou
work
laboratori
establish
mab
glycoprotein
neutral
viru
vitro
collin
et
extend
find
survey
larger
panel
antibodi
el
glycoprotein
use
sensit
plaqu
reduct
assay
determin
prd
titer
monoclon
ascit
prepar
use
present
studi
titer
observ
rang
approxim
prd
ml
greater
prd
ml
variou
ascit
prepar
summar
tabl
note
low
background
titer
gener
less
prddml
observ
prepar
nucleocapsid
specif
antibodi
well
unrel
monoclon
ascit
normal
mous
sera
data
shown
whether
natur
occur
activ
repres
specif
antibodi
crossreact
natur
antibodi
investig
passiv
transfer
mab
block
lethal
enceph
induc
intracerebr
inocul
balbc
mice
exquisit
sensit
infect
neuron
cn
result
rapidli
lethal
enceph
usual
within
day
test
two
passiv
transfer
regimen
describ
materi
method
attempt
alter
cours
normal
lethal
enceph
regimen
effect
simpler
singl
antibodi
dose
protocol
adopt
figur
show
result
one
protect
experi
test
five
differ
mab
glycoprotein
control
singl
antibodi
n
protein
group
six
mice
given
indic
ascit
dayl
challeng
intracerebr
pfu
day
survivor
observ
daili
day
sacrif
order
score
demyelin
lesion
spinal
cord
note
mice
receiv
nonprotect
antibodi
clone
time
dose
depend
passiv
protecticm
effect
antibodi
given
passiv
prior
infect
might
argu
simpli
vivo
neutral
wherebi
incom
viru
challeng
inoculum
prevent
infect
target
cn
test
possibl
alter
time
antibodi
transfer
rel
challeng
group
six
mice
given
singl
dose
mab
day
l
rel
viru
challeng
day
mortal
score
interv
evid
fig
group
six
mice
receiv
antibodi
mab
day
die
day
infect
previous
observ
contrast
mice
receiv
antibodi
day
l
show
surviv
respect
receiv
antibodi
day
infect
surviv
day
thu
effect
passiv
transfer
antibodi
therapeut
confer
protect
even
given
establish
cn
infect
examin
quantiti
antibodi
requir
protect
lethal
challeng
gave
group
six
mice
increas
dose
ascit
day
prior
ic
challeng
score
mortal
indic
tabl
summar
result
typic
experi
singl
dose
ascit
neutral
titer
l
lo
ooo
protect
half
challeng
mice
dose
ascit
g
mous
approxim
equival
l
dilut
blg
eflect
passiv
transfer
antibodi
viru
growth
tissu
observ
mab
protect
even
given
challeng
suggest
spare
effect
oper
block
slow
spread
viru
infect
investig
titer
mhv
infect
tissu
follow
infect
presenc
absenc
protect
antibodi
brain
liver
titer
assess
effect
antibodi
replic
cn
peripher
tissu
respect
mab
passiv
transfer
day
ic
challeng
tissu
remov
titrat
day
infect
time
suffici
unprotect
mice
remain
aliv
studi
tabl
summar
result
note
titer
brain
mice
receiv
mab
reduc
factor
rel
untreat
control
reduct
observ
mice
receiv
nonprotect
antibodi
el
protect
mice
group
iv
tabl
unabl
detect
viru
liver
threshold
valu
pfu
per
gram
wherea
control
mice
group
iii
greater
x
pfu
per
gram
liver
day
confirm
differ
reflect
actual
reduct
viru
replic
mere
damp
effect
due
high
concentr
mab
liver
homogen
examin
h
e
section
well
fluoresceinstain
cryostat
section
liver
protect
unprotect
mice
mice
receiv
protect
mab
show
numer
larg
necrot
foci
hepatocyt
fig
stain
antigen
fig
limit
isol
foci
infect
cell
observ
section
liver
mice
receiv
protect
mab
fig
taken
togeth
find
indic
viru
replic
substanti
decreas
passiv
administ
mab
cn
peripher
compart
et
al
observ
lower
viru
titer
brain
protect
mice
suggest
viru
replic
restrict
fewer
cell
anim
test
compar
distribut
mhv
antigen
section
spinal
cord
among
infect
untreat
infect
unprotect
infect
protect
mice
figur
demonstr
peroxidaselabel
mhv
antigen
section
mhvlinfect
untreat
mous
mhv
antigen
neuron
cell
gray
matter
fig
well
oligodendrocyt
process
surround
multipl
myelin
sheath
white
matter
fig
antigen
distribut
infect
anim
given
nonprotect
antibodi
virtual
ident
contrast
mice
infect
protect
antibodi
differ
distribut
mhv
antigen
figur
demonstr
peroxidaselabel
mhv
antigen
oligodendrocyt
identifi
cytoplasm
process
surround
multipl
myelin
sheath
knobler
et
ul
knobler
et
ul
white
matter
neuron
contain
mhv
antigen
usual
found
spinal
cord
antibodyprotect
mice
find
corrobor
histopatholog
myelin
neuron
mice
infect
protect
antibodi
spare
anim
definit
area
demyelin
fig
demyelin
foci
frequent
associ
perivascular
infiltr
mononuclear
cell
fig
demonstr
demyelin
presenc
protect
antibodi
suggest
effect
antibodi
differ
neuron
oligodendrocyt
sinc
ts
mutant
caus
infect
oligodendrocyt
evalu
effect
protect
antibodi
demyelin
diseas
induc
ts
viru
two
group
seven
mice
receiv
either
protect
mab
antibodi
group
challeng
day
later
pfu
ts
viru
ic
demyelin
found
mice
examin
group
suggest
mab
protect
neuron
cell
histopatholog
diseas
similarli
protect
oligodendrocyt
ts
mutant
mhvjhm
haspel
et
al
viru
show
decreas
encephalitogen
retain
abil
induc
cn
demyelin
present
studi
investig
influenc
infect
passiv
transfer
antibodi
singl
epitop
viral
glycoprotein
result
demonstr
specif
monoclon
antibodi
glycoprotein
block
enceph
convert
normal
lethal
infect
nonfat
demyelin
diseas
spare
effect
upon
passiv
transfer
restrict
subset
mab
react
b
epitop
properti
antibodi
epitop
c
mab
mhv
el
n
polypeptid
talbot
et
al
although
protect
antibodi
examin
neutral
viru
infect
vitro
one
mab
direct
epitop
c
neutral
viru
effici
vitro
show
spare
effect
viva
thu
properti
vitro
neutral
tivo
protect
distinguish
appear
map
distinct
subset
epitop
protect
antibodi
prevent
infect
cn
cell
mhv
replic
decreas
complet
block
antibodi
viru
titer
brain
mice
treat
protect
dose
antibodi
prior
infect
approxim
reach
control
unprotect
mice
tabl
antibodi
found
effect
confer
protect
given
late
day
viru
challeng
fig
thu
spare
effect
therapeut
titer
viru
sever
patholog
lessen
prophylact
lethal
enceph
prevent
unlik
absenc
liver
lesion
antibodyprotect
mice
signific
factor
surviv
sinc
much
larger
dose
pfu
use
studi
caus
subacut
hepat
given
intraperiton
mechan
antibodymedi
protect
function
appear
block
spread
infect
neuron
appar
data
tabl
viru
replic
brain
protect
mice
diminish
level
rel
control
mice
neuron
bear
viral
antigen
could
demonstr
brain
immunofluoresc
data
shown
evid
mhv
replic
found
neuron
spinal
cord
spare
effect
mab
select
neuron
cell
infect
oligodendrocyt
result
demyelin
observ
spinal
cord
infect
passiv
protect
mice
fig
antibodi
protect
lethal
enceph
block
demyelin
induc
ts
mutant
observ
restrict
viru
replic
neuron
cell
oligodendrocyt
suggest
infect
spread
via
differ
mechan
two
cell
type
whether
due
differ
mode
celltocel
spread
reflect
distinct
receptor
cell
type
matter
studi
addit
alter
viru
tropism
presenc
antibodi
found
characterist
demyelin
lesion
chang
lesion
antibodyprotect
mice
show
increas
cellular
frequent
perivascular
cuf
contrast
lesion
usual
observ
follow
infect
model
system
demonstr
antibodi
respons
precis
defin
region
viral
glycoprotein
may
induc
profound
chang
pathogenesi
infect
phenotyp
diseas
conceptu
factor
may
import
follow
primari
infect
earli
respons
critic
epitap
might
influenc
cours
diseas
stohlman
weiner
shown
mice
surviv
acut
encephalomyel
neutral
antibodi
circul
develop
chronic
demyelin
similarli
repertoir
respons
primari
infect
may
influenc
cours
subsequ
infect
relat
viru
human
viral
diseas
subacut
scleros
panenceph
vandvik
progress
rubella
panenceph
wolinski
et
al
occur
presenc
high
titer
antibodi
measl
rubella
virus
respect
human
demyelin
diseas
multipl
sclerosi
elev
titer
antibodi
number
common
virus
measl
varicella
herp
other
norrbi
although
causal
relationship
respect
virus
presenc
antibodi
demyelin
diseas
establish
present
model
system
provid
new
insight
potenti
role
select
specif
antibodi
lead
host
surviv
fatal
infect
develop
chronic
diseas
final
model
offer
opportun
studi
factor
govern
infect
spread
within
specif
popul
cn
cell
molecular
level
